Working… Menu

A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01275105
Recruitment Status : Completed
First Posted : January 12, 2011
Last Update Posted : March 6, 2012
ORA, Inc.
Information provided by (Responsible Party):
Eye Therapies, LLC

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 2011
Actual Study Completion Date : March 2011
Certification/Extension First Submitted : February 24, 2012